Nationwide Outcomes of Advanced Melanoma According to BRAF(V600) Status

van Breeschoten, J; Wouters, MWJM; de Wreede, LC; Hilarius, DH; Haanen, JB; Blank, CU; Aarts, MJB; van den Berkmortel, FWPJ; de Groot, JWB; Hospers, GAP; Kapiteijn, E; Piersma, D; van Rijn, RS; Suijkerbuijk, KPM; Blokx, WAM; ten Tije, AJ; van der Veldt, AAM; Vreugdenhil, G; Boers, MJ; van den Eertwegh, AJM

van Breeschoten, J (corresponding author), Amsterdam UMC, Locat VUMC, Dept Med Oncol, Boelelaan 1118, NL-1081 HZ Amsterdam, Netherlands.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021; 44 (2): 82

Abstract

Objective: The aim of this study was to evaluate treatment patterns and overall survival (OS) of patients with BRAF(V600) wild-type and BRAF(V600)-mut......

Full Text Link